Internal Medicine, Medical Oncology · Orange, CA
NPI
1154380582
Since 2006
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
101 the City Dr S
Orange, CA, 92868
Phone (714) 456-8888
Groups this clinician bills Medicare through
Medicare paid, 2024
$75K
642 services
Medicare patients, 2024
188
Average age 72
Drug cost, 2024
$2.2M
652 prescriptions
Company payments, 2025
$14K
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Victoria M Villaflor was code 99215 (office e&m - established), 520 times for 167 patients. In total Victoria M Villaflor billed 642 services in 12 codes, and Medicare paid $75K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99215 Office E&M - Established | Facility | 520 | 167 | $120.71 | $63K |
| 99205 Office E&M - New | Facility | 41 | 41 | $152.38 | $6,247 |
| 99232 Hospital E&M - Subsequent | Facility | 23 | 13 | $66.99 | $1,541 |
| 99233 Hospital E&M - Subsequent | Facility | 20 | 13 | $101.13 | $2,023 |
By year: 2022 $79K for 649 services; 2023 $92K for 832 services; 2024 $75K for 642 services.
Medicare prescription drug claims, 2024
In 2024, the drug Victoria M Villaflor prescribed most often to Medicare patients was Ondansetron Hcl, with 76 prescriptions and refills. In total Victoria M Villaflor wrote 652 Medicare prescriptions that cost $2.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ondansetron Hcl Generic | 76 | 76 | 35 | $1,052 |
| Prochlorperazine Maleate Generic | 55 | 55 | 32 | $471 |
| Mekinist Trametinib Dimethyl Sulfoxide | 55 | 55 | 12 | $826K |
| Tafinlar Dabrafenib Mesylate | 55 | 55 | 12 | $671K |
| Dexamethasone Generic | 48 | 48 | 26 | $713 |
| Famotidine Generic | 42 | 48 | 19 | $158 |
| Gabapentin Generic | 31 | 33 | 14 | $294 |
| Pantoprazole Sodium Generic | 28 | 39 | Under 11 | $216 |
| Retevmo Selpercatinib | 28 | 28 | Under 11 | $627K |
| Levothyroxine Sodium Generic | 23 | 41 | Under 11 | $115 |
| Metoclopramide Hcl Generic | 16 | 18 | Under 11 | $46.73 |
| Sodium Chloride 0.9 % Sodium Chloride | 14 | 14 | Under 11 | $647 |
| Fluconazole Generic | 12 | 12 | Under 11 | $292 |
| Prednisone Generic | 12 | 16 | Under 11 | $49.63 |
Brand drugs: 181 claims; generic drugs: 471 claims; opioid claims: 16.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Victoria M Villaflor $14K ($14K in general payments such as food, travel and fees) from 6 companies. The largest payer was Coherus Oncology, Inc. with $14K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.